Frontlight ResearchEarly access
Childhood cancers trials in United States
933 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in United StatesDepletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome
- Where
- Seattle
- People
- 52
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT07819396 - No phaseTaking people[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- People
- 300
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT00588185 - Phase 1/2Taking peopleCBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Where
- Ann Arbor, Atlanta, Aurora, Baltimore, Birmingham, Boston, Buffalo, Chicago, Cincinnati, Dallas, Durham, Fort Worth, Houston, Indianapolis, Kansas City, Los Angeles, Memphis, Milwaukee, Minneapolis, New York, Orange, Philadelphia, Phoenix, Pittsburgh, Portland, Salt Lake City, San Francisco, Seattle, St Louis, St. Petersburg, Valhalla, Washington D.C.
- Age
- 12 months to 21 years
- People
- 63 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT04870944 - Phase 1/2Taking peopleSJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
- Where
- Memphis
- Age
- 2 years to 24 years
- People
- 132
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT04923126 - Phase 1Taking peopleTargeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
- Where
- Aurora, Boston, Columbus, Gainsville, Grand Rapids, Houston, Indianapolis, Loma Linda, Los Angeles, Milwaukee, Philadelphia, Phoeniz, San Francisco, St. Petersburg, Vallhala, Washington D.C.
- Age
- Up to 39 years
- People
- 30
- Run by
- New York Medical College
See details and how to joinNCT04972942 - No phaseTaking peopleBiospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
- Where
- Atlanta, Baltimore, Boston, Cincinnati, Columbus, Dallas, Denver, Houston, Indianapolis, Iowa City, Los Angeles, Milwaukee, Minneapolis, New Orleans, Oakland, Palo Alto, Philadelphia, Pittsburgh, San Antonio, St Louis
- Age
- Up to 17 years
- People
- 1,600 worldwide
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06651580 - Phase 3Taking peopleStudy to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
- Where
- Atlanta, Austin, Dallas, Denver, Detroit, Edgewood, Fairfax, Fayetteville, Hartford, Jacksonville, Nashville, New Haven, New Orleans, New York, Norfolk, Orlando, Scottsdale, Tacoma, Wytheville
- Age
- 12 years to 100 years
- People
- 240 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06784752 · EU 2024-518325-15-00 - Phase 1Taking peopleDetermine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma
- Where
- Chicago
- Age
- 6 years to 21 years
- People
- 56
- Run by
- Cerenome
See details and how to joinNCT07061626 - No phaseTaking peopleFinancial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
- Where
- Houston
- People
- 100
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07215611 - Phase 2Not yet taking people in United StatesFianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma
- Where
- Orange
- People
- 35
- Run by
- University of California, Irvine
See details and how to joinNCT07527325 - No phaseNot yet taking people in United StatesStrengthening Teen Brain Resilience Using Music Intervention to Improve Radiation Induced Cognitive Decline for Adolescents Undergoing Radiation Therapy for Cancer Treatment
- Where
- Scottsdale
- Age
- 12 years to 17 years
- People
- 30
- Run by
- Mayo Clinic
See details and how to joinNCT07729384 - No phaseNot yet taking people in United StatesA Study Of Remote Patient Monitoring (RPM) Program For Cancer Patients Initiating Cancer-directed Therapy
- Where
- Rochester
- Age
- 1 year and over
- People
- 470
- Run by
- Mayo Clinic
See details and how to joinNCT07810400 - No phaseNot yet taking people in United StatesA Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment
- Where
- Boston
- People
- 30,000
- Run by
- Harvard Medical School (HMS and HSDM)
See details and how to joinNCT07814872 - Phase 1/2Taking peopleInotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- Where
- Boston, Cleveland, Columbus, New York, Omaha, Westwood
- Age
- 16 years to 75 years
- People
- 44
- Run by
- Leland Metheny
See details and how to joinNCT03104491 - No phaseTaking peopleImpact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
- Where
- Aurora
- Age
- 5 years to 13 years
- People
- 152
- Run by
- University of Colorado, Denver
See details and how to joinNCT04993859 - No phaseEnrolling by invitationDeveloping Biomarkers of Plexiform Tumor Burden in Patients With Neurofibromatosis-Type 1
- Where
- Chicago
- People
- 200
- Run by
- Ann & Robert H Lurie Children's Hospital of Chicago
See details and how to joinNCT05238909 - No phaseNot yet taking people in United StatesVR-PAT and fNIRS to Identify CNS Biomarkers of Pain
- Where
- Columbus
- Age
- 6 years to 17 years
- People
- 4
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT06303687 - Phase 2Taking peopleTrial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.
- Where
- Palo Alto
- Age
- 12 years and over
- People
- 80
- Run by
- Stanford University
See details and how to joinNCT07594431 - Phase 1Taking peopleNgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
- Where
- Washington D.C.
- Age
- 3 years to 25 years
- People
- 30
- Run by
- Children's National Research Institute
See details and how to joinNCT07664176 - Phase 1Taking peoplePhase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Where
- Ann Arbor, Atlanta, Aurora, Beverly Hills, Charlottesville, Chicago, Cincinnati, Cleveland, Duarte, Fairfax, Grand Rapids, Houston, Los Angeles, Nashville, New York, Orange, Philadelphia, Portland, San Antonio, San Diego, San Francisco, Santa Monica, Scottsdale
- Age
- 12 years to 85 years
- People
- 411 worldwide
- Run by
- Inhibrx Biosciences, Inc
See details and how to joinNCT03715933 · EU 2023-508139-29-00 - Phase 2Taking peopleBrentuximab Vedotin and Nivolumab for the Treatment of Relapsed/Refractory Classic Hodgkin Lymphoma Previously Treated With Brentuximab Vedotin or Checkpoint Inhibitors
- Where
- Atlanta
- Age
- 12 years and over
- People
- 46
- Run by
- Emory University
See details and how to joinNCT05039073 - No phaseTaking peopleTargeted Pediatric High-Grade Glioma Therapy
- Where
- Ann Arbor, Aurora, Boston, Chicago, Cincinnati, Columbus, Durham, Houston, Miami, Philadelphia, Seattle, Washington D.C.
- Age
- 12 months to 39 years
- People
- 350 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05839379 - Phase 2Taking peopleCytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
- Where
- Houston
- People
- 100
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT02479698 - Phase 2Taking peoplePediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Where
- Augusta, Austin, Birmingham, Boise, Charleston, Charlotte, Chicago, Dallas, Grand Rapids, Hackensack, Hartford, Hershey, Honolulu, Kansas City, Little Rock, Louisville, Miami, Minneapolis, Oakland, Orlando, Portland, San Diego, St Louis, Tampa
- Age
- Up to 22 years
- People
- 500 worldwide
- Run by
- Giselle Sholler
See details and how to joinNCT02559778 - Phase 2Taking peopleAzacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- Where
- Baltimore, Cleveland, Houston
- Age
- 12 years and over
- People
- 63
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03383575